Willow Biosciences OTC Stock Forward View - Simple Regression
| CANSF Stock | USD 0.12 0.01 9.09% |
Willow OTC Stock outlook is based on your current time horizon. We recommend always using this module together with an analysis of Willow Biosciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 30th of January 2026, The value of RSI of Willow Biosciences' share price is at 50 suggesting that the otc stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Willow Biosciences, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Willow Biosciences based on different types of headlines from major news networks to social media. Using Willow Biosciences hype-based prediction, you can estimate the value of Willow Biosciences from the perspective of Willow Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Willow Biosciences on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.45. Willow Biosciences after-hype prediction price | USD 0.12 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Willow |
Willow Biosciences Additional Predictive Modules
Most predictive techniques to examine Willow price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Willow using various technical indicators. When you analyze Willow charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Willow Biosciences Simple Regression Price Forecast For the 31st of January
Given 90 days horizon, the Simple Regression forecasted value of Willow Biosciences on the next trading day is expected to be 0.12 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.000093, and the sum of the absolute errors of 0.45.Please note that although there have been many attempts to predict Willow OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Willow Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Willow Biosciences OTC Stock Forecast Pattern
| Backtest Willow Biosciences | Willow Biosciences Price Prediction | Buy or Sell Advice |
Willow Biosciences Forecasted Value
In the context of forecasting Willow Biosciences' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Willow Biosciences' downside and upside margins for the forecasting period are 0 and 9.85, respectively. We have considered Willow Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Willow Biosciences otc stock data series using in forecasting. Note that when a statistical model is used to represent Willow Biosciences otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.83 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0074 |
| MAPE | Mean absolute percentage error | 0.0629 |
| SAE | Sum of the absolute errors | 0.4524 |
Predictive Modules for Willow Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Willow Biosciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Willow Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Willow Biosciences After-Hype Price Density Analysis
As far as predicting the price of Willow Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Willow Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Willow Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Willow Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Willow Biosciences' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Willow Biosciences' historical news coverage. Willow Biosciences' after-hype downside and upside margins for the prediction period are 0.01 and 9.85, respectively. We have considered Willow Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Willow Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Willow Biosciences is based on 3 months time horizon.
Willow Biosciences OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Willow Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Willow Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Willow Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.45 | 9.73 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.12 | 0.12 | 0.00 |
|
Willow Biosciences Hype Timeline
Willow Biosciences is currently traded for 0.12. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Willow is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.45%. %. The volatility of related hype on Willow Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.12. About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Willow Biosciences last dividend was issued on the 21st of May 2019. The entity had 1:25 split on the 21st of May 2019. Assuming the 90 days horizon the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Willow Biosciences to cross-verify your projections.Willow Biosciences Related Hype Analysis
Having access to credible news sources related to Willow Biosciences' direct competition is more important than ever and may enhance your ability to predict Willow Biosciences' future price movements. Getting to know how Willow Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Willow Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELIXF | Elixxer | 0.00 | 0 per month | 0.00 | 0.13 | 13.85 | (19.05) | 719.30 | |
| LEEEF | Leef Brands | 0.00 | 0 per month | 0.00 | (0.14) | 6.67 | (9.09) | 29.86 | |
| CBSTF | The Cannabist | 0.00 | 0 per month | 12.53 | 0.03 | 25.86 | (17.50) | 137.60 | |
| SNNVF | Sunniva | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ITHUF | iAnthus Capital Holdings | 0.00 | 0 per month | 9.58 | 0.01 | 25.00 | (20.00) | 53.97 | |
| CXXIF | C21 Investments | 0.00 | 0 per month | 7.53 | 0.01 | 12.50 | (11.76) | 81.83 | |
| DXBRF | BellRock Brands | 0.00 | 0 per month | 0.00 | (0.13) | 0.00 | 0.00 | 100.00 | |
| MDDVF | Medical Developments International | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 23.33 | |
| TCNAF | TransCanna Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MRMD | Marimed | 0.00 | 0 per month | 0.00 | (0.03) | 10.00 | (10.00) | 60.95 |
Other Forecasting Options for Willow Biosciences
For every potential investor in Willow, whether a beginner or expert, Willow Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Willow OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Willow. Basic forecasting techniques help filter out the noise by identifying Willow Biosciences' price trends.Willow Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Willow Biosciences otc stock to make a market-neutral strategy. Peer analysis of Willow Biosciences could also be used in its relative valuation, which is a method of valuing Willow Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Willow Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Willow Biosciences otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Willow Biosciences shares will generate the highest return on investment. By undertsting and applying Willow Biosciences otc stock market strength indicators, traders can identify Willow Biosciences entry and exit signals to maximize returns.
Willow Biosciences Risk Indicators
The analysis of Willow Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Willow Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting willow otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.39 | |||
| Semi Deviation | 7.48 | |||
| Standard Deviation | 9.73 | |||
| Variance | 94.74 | |||
| Downside Variance | 124.04 | |||
| Semi Variance | 55.91 | |||
| Expected Short fall | (12.64) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Willow Biosciences
The number of cover stories for Willow Biosciences depends on current market conditions and Willow Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Willow Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Willow Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Willow OTC Stock
Willow Biosciences financial ratios help investors to determine whether Willow OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.